Answers are grounded in this paper and cite their sources.
Among patients with advanced heart failure, a fully magnetically levitated centrifugal-flow left ventricular assist device was associated with less frequent need for pump replacement than an axial-flow device and was superior with respect to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device. (Funded by Abbott; MOMENTUM 3 ClinicalTrials.gov number, NCT02224755.).
No takes yet. Share an insight, caveat, or question.
Mehra et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: